Meghamsh Kanuparthy

Department of Surgery, Brown University

Affiliated withBrown University Rhode Island Hospital

Research Area

Biography

Meghamsh Kanuparthy has not added Biography.
If you are Meghamsh Kanuparthy and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title	2025
Publication title Cited by 1	2025

Other Publications

Article	Year
Intramyocardial Injection of Hypoxia-Conditioned Extracellular Vesicles Modulates Response to Oxidative Stress in the Chronically Ischemic Myocardium. Bioengineering (Basel, Switzerland)\| PubMed ID: 38391611	2024
Crafting a Rigorous, Clinically Relevant Large Animal Model of Chronic Myocardial Ischemia: What Have We Learned in 20 Years? Methods and protocols\| PubMed ID: 38392691	2024
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia. Biomedicines\| PubMed ID: 38540200	2024
Effects of diet-induced metabolic syndrome on cardiac function and angiogenesis in response to the sodium-glucose cotransporter-2 inhibitor canagliflozin. The Journal of thoracic and cardiovascular surgery\| PubMed ID: 38879117	2024
Metformin Preconditioning Augments Cardiac Perfusion and Performance in a Large Animal Model of Chronic Coronary Artery Disease. Annals of surgery\| PubMed ID: 39041226	2024
Intramyocardial injection of hypoxia-conditioned extracellular vesicles increases myocardial perfusion in a swine model of chronic coronary disease. JTCVS open\| PubMed ID: 39296447	2024
Gender, race, and ethnicity in lung cancer clinical trial participation: Analysis of 253,845 patients from 2002 to 2021. The Journal of thoracic and cardiovascular surgery\| PubMed ID: 39349163	2025
Sodium-Glucose Cotransporter-2 Inhibition Normalizes Metabolic Derangements in the Ischemic Myocardium. The Journal of surgical research\| PubMed ID: 39437599	2024
Protein Kinase C-β Inhibition and Survival Signaling after Simulated Cardioplegic-Ischemia/Reperfusion in Nondiabetic and Diabetic Human Coronary Arterial Endothelial Cells. Journal of the American College of Surgeons\| PubMed ID: 39651752	2025
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 39665144	2025
Lab-grown, 3D extracellular matrix particles improve cardiac function and morphology in myocardial ischemia. American journal of physiology. Heart and circulatory physiology\| PubMed ID: 39705507	2025
Impaired cerebral microvascular reactivity and endothelial SK channel activity in a streptozotocin-treated mouse model of Alzheimer's disease. Journal of Alzheimer's disease : JAD\| PubMed ID: 39791382	2025
Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension. Biomedicines\| PubMed ID: 40002822	2025
Dipeptidyl peptidase-4 inhibitor linagliptin improves fibrosis, apoptosis, and cardiac function in a large animal model of chronic myocardial ischemia. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 40023609	2025
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome. International journal of molecular sciences\| PubMed ID: 40076513	2025
Linagliptin Modulation of Inflammation in Chronic Coronary Artery Disease. The Journal of surgical research\| PubMed ID: 40253935	2025
Linagliptin exerts a sex-specific effect on cardiac function, collateralization, and metabolism in a swine model of cardiometabolic disease. The Journal of thoracic and cardiovascular surgery\| PubMed ID: 40324745	2025
Preoperative dementia in patients undergoing coronary artery bypass grafting: A propensity-matched analysis. Surgery\| PubMed ID: 40344991	2025
Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces lung fibrosis in left heart dysfunction. Asian cardiovascular & thoracic annals\| PubMed ID: 40605641	2025
Impaired contractile response of human peripheral arterioles to angiotensin II after cardiopulmonary bypass. Surgery\| PubMed ID: 40651273	2025
Sodium-glucose Cotransporter-2 Canagliflozin's impact on cardiovascular disease in the setting of metabolic syndrome: A proteomic analysis. European journal of pharmacology\| PubMed ID: 40683440	2025